Skip to content

Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Irritable Bowel Syndrome and Healthy Subjects

Evaluation of the Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Patients With Irritable Bowel Syndrome and Healthy Subjects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03366389
Enrollment
114
Registered
2017-12-08
Start date
2017-06-07
Completion date
2017-10-20
Last updated
2017-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Brief summary

In this observational case-control study investigators aimed to assess the serum levels of adipokines such as Apelin, Chemerin and adiponectin in patients with irritable bowel syndrome (IBS), and compare it with healthy controls. Furthermore, investigators evaluated the possible correlation of these adipokines with IBS-QoL, IBSSS, GI symptoms and other clinical and psychological disorders.

Interventions

None listed

Sponsors

Lorestan University of Medical Sciences
CollaboratorOTHER
Amir Abbasnezhad
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women between the ages of 18, and 80 years. * IBS patients diagnosed according to the Rome III Diagnostic Criteria for Functional GI Disorders.

Exclusion criteria

* Any evidence of abdominal surgery or radiation * celiac disease, or other primary GI illnesses * GI infection obscuring IBS symptoms, * using total parenteral nutrition therapy in the last 6 months * pregnancy and lactation * alcohol consumption * concurrent chronic diseases such as diabetes, renal failure * diagnosed and/or treated malignancy in the past 5 years * anti-inflammatory drugs usage * intake of vitamin D, omega-3, vitamin E, and calcium supplements * being on a special diet or medication regimen during the last 6 months

Design outcomes

Primary

MeasureTime frame
Serum levels of Apelin, Chemerin and adiponectinin recruitment

Secondary

MeasureTime frameDescription
IBS severity score system (IBSSS)in recruitmentIrritable bowel syndrome severity score system is validated for use in IBS patients, which included five clinically relevant items during a 10-day period: (i) severity of abdominal pain, (ii) frequency of abdominal pain, (iii) severity of abdominal distention or tightness, (iv) dissatisfaction with bowel habits, and (v) interference of IBS with life in general. Each item was scored on a scale from 0 to 100, and the sum of these five items was the score of IBS severity (range 0-500). Scores of 75-175, 175-300, and \>300 indicated mild, moderate, and severe cases, respectively.
Gastrointestinal symptomsin recruitment
IBS-Quality of life (IBS-QoL)in recruitmentThe Quality of life was assessed at the baseline and at the end of the study using a self-report QoL measure specific to IBS (IBS-QoL) with 34 items
Personalityin recruitmentBig Five Inventory Questionnaire
Perceived Stress Scalein recruitmentThe Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful.Higher PSS scores were associated with a greater vulnerability to stressful life-event-elicited depressive symptoms. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items. A short 4 item scale can be made from questions 2, 4, 5 and 10 of the PSS 10 item scale.
Somatic Symptomin recruitment

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026